1st Quarter - Report
FORBES-TATE for CSL BEHRING
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| RICHARD FERNANDO LOPEZ | — |
| BARRETT THORNHILL | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| RICHARD FERNANDO LOPEZ | — |
| BARRETT THORNHILL | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.